title: Case report and literature review: Metastatic lobular carcinoma of the breast an unusual presentation.
abstract: BACKGROUND
  Invasive lobular carcinoma is the second most common type of invasive breast carcinoma (between 5% and 15%). The incidence of invasive lobular carcinoma has been increasing while the incidence of invasive duct carcinoma has not changed in the last two decades. This increase is postulated to be secondary to an increased use of combined replacement hormonal therapy. Patients with invasive lobular carcinoma tend to be slightly older than those with non-lobular invasive carcinoma with a reported mean age of 57 years compared to 64 years. On mammography, architectural distortion is more common and microcalcifications less common with invasive lobular carcinoma than invasive ductal carcinoma. The incidence of extrahepatic gastrointestinal (GI) tract metastases observed in autopsy studies varies in the literature from 6% to 18% with the most commonly affected organ being the stomach, followed by colon and rectum. Gastric lesions seem to be slightly more frequent, compared to colorectal lesions (6-18% compared to 8-12%, respectively).
  
  
  METHODS
  We present the case of a 70-year-old woman who was referred to our institution with a concurrent gastric and rectal cancer that on further evaluation was diagnosed as metastatic invasive lobular carcinoma of the breast. She has a stage IV clinical T3N1M1 left breast invasive lobular carcinoma (ER positive at 250, PR negative, HER-2/neu 1+ negative) with biopsy proven metastases to left axillary lymph nodes, gastric mucosa, peritoneum, rectal mass, and bone who presented with a partial large bowel obstruction. She is currently being treated with weekly intravenous paclitaxel, bevacizumab that was added after her third cycle, and she is also receiving monthly zoledronic acid. She is currently undergoing her 12-month of treatment and is tolerating it well. Discussion Breast cancer is the most common site-specific cancer in women and is the leading cause of death from cancer for women aged 20-59 years. It accounts for 26% of all newly diagnosed cancers in females and is responsible for 15% of the cancer-related deaths in women.(9) Breast cancer is one of the most common malignancies that metastasize to the GI tract, along with melanoma, ovarian and bladder cancer.
  
  
  CONCLUSIONS
  We present one of the first reports of metastatic lobular breast cancer presenting as a synchronous rectal and gastric tumors. Metastatic lobular carcinoma of the breast is a rare entity with a wide range of clinical presentations. A high level of suspicion, repetition of endoscopic procedures, and a detailed pathological analysis is necessary for early diagnosis, which might help to avoid surgical treatment due to incorrect diagnosis. Patients with a history of breast cancer who present with new gastrointestinal lesions should have these lesions evaluated for evidence of metastasis through histopathologic evaluation and immunohistochemical analysis. Differentiating between a primary GI lesion and metastatic breast cancer will allow initiation of appropriate treatment and help prevent unnecessary operations.
authors.affiliation: Fox Chase Cancer Center, United States.
authors.forename: Rodrigo
authors.initials: R
authors.lastname: Arrangoiz
authors.forename: Pavlos
authors.initials: P
authors.lastname: Papavasiliou
authors.forename: Holly
authors.initials: H
authors.lastname: Dushkin
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Farma
references.citation: Ann Oncol. 2001 May;12(5):715-8
references.pmid: 11432633
references.citation: J Surg Oncol. 1991 Sep;48(1):28-33
references.pmid: 1653879
references.citation: Eur J Surg Oncol. 1990 Apr;16(2):121-6
references.pmid: 2157608
references.citation: Mod Pathol. 1995 May;8(4):427-33
references.pmid: 7567944
references.citation: Cancer. 1996 Jan 1;77(1):113-20
references.pmid: 8630916
references.citation: Breast Cancer Res Treat. 2008 Sep;111(1):121-7
references.pmid: 17929165
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references.pmid: 18287387
references.citation: Clin Transl Oncol. 2010 Feb;12(2):150-3
references.pmid: 20156785
references.citation: World J Surg. 2007 Aug;31(8):1597-601
references.pmid: 17578645
references.citation: J Clin Oncol. 1998 Nov;16(11):3711-3
references.pmid: 9817292
references.citation: Gastrointest Endosc. 1992 Mar-Apr;38(2):136-41
references.pmid: 1568609
references.citation: Cancer. 1986 Apr 1;57(7):1376-9
references.pmid: 3948119
references.citation: Br J Cancer. 1984 Jul;50(1):23-30
references.pmid: 6331484
references.citation: Am Surg. 2006 May;72(5):456-60
references.pmid: 16719204
references.citation: Dis Colon Rectum. 2001 Mar;44(3):453-5
references.pmid: 11289296
references.citation: In Vivo. 2006 Jan-Feb;20(1):165-8
references.pmid: 16433047
references.citation: JAMA. 2003 Mar 19;289(11):1421-4
references.pmid: 12636465
references.citation: Am J Gastroenterol. 1998 Jan;93(1):111-4
references.pmid: 9448188
references.citation: Ann Gastroenterol Hepatol (Paris). 1992 Jun-Sep;28(4):175-7
references.pmid: 1444182